1. FRI0513 TREATMENT PERSISTENCE IN PATIENTS CYCLING ON SUBCUTANEOUS TUMOR NECROSIS FACTOR-ALPHA INHIBITORS IN INFLAMMATORY ARTHRITIS – A RETROSPECTIVE STUDY. (13th June 2020) Authors: Dalén, J.; Puenpatom, A.; Luttropp, K.; Black, C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-152 Epidemiological trends of HPV-related head and neck cancer in males: a systematic literature review. (March 2019) Authors: Morais, E.; Wang, X.; Luttropp, K.; Nicholson, M.; Varga, S.; Eriksson, J.; Wong, J.R.; Drury, R.; Kothari, S.; Walia, A. Journal: Radiotherapy and oncology Issue: Volume 132(2019)Supplement 1 Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0666 Costs associated with switching subcutaneous tumour necrosis factor-Α inhibitor in the treatment of immune-mediated rheumatic disease. (12th June 2018) Authors: Dalén, J.; Svedbom, A.; Luttropp, K.; Kachroo, S. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗